Optimization of an Enzyme Immunoassay for 11-Dehydro-Thromboxane B2 in Urine: Comparison with GC-MS
- 15 December 1999
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 96 (6) , 427-436
- https://doi.org/10.1016/s0049-3848(99)00126-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Analysis of urinary 11-dehydrothromboxane B2 in patients with occluded retinal vein using GC/SIMProstaglandins, Leukotrienes & Essential Fatty Acids, 1998
- Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplastyJournal of the American College of Cardiology, 1993
- Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in manBiochimica et Biophysica Acta (BBA) - General Subjects, 1989
- Paired analysis of urinary thromboxane B2 metabolites in humansThrombosis Research, 1987
- Radioimmunoassay for 11-dehydro-TXB2: A method for monitoring thromboxane production in vivoProstaglandins, 1986
- 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.Proceedings of the National Academy of Sciences, 1986
- Identification of 11-dehydro-TXB2 as a suitable parameter for monitoring thromboxane production in the humanProstaglandins, 1986
- Long-lived enzymatic metabolites of thromboxane B2 in the human circulationAnalytical Biochemistry, 1986
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975